Literature DB >> 9592943

Temporary suppression of cell-mediated immunity in standardbred horses with decreased athletic capacity.

M Jensen-Waern1, S G Persson, A Nordengrahn, M Mérza, C Fossum.   

Abstract

Eighty Standardbred horses, originating from 5 training campuses, with decreased athletic performance in association with symptoms such as intermittent fever and mild pharyngitis were examined. As control animals, 10 horses from a stable with normally performing horses were used. Virus isolation and clinico-chemical and serological tests were performed. Lymphocyte proliferation tests were carried out to evaluate the capacity of the cell-mediated immunity. In addition, a bioassay for equine type I interferon, as a marker for early viral infections, was established. No specific microbe could be linked to these symptoms, but there was a temporary suppression of the cell-mediated immunity, which might be explained by the serological evidence of an EHV-2 and/or rhinovirus infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9592943      PMCID: PMC8050687     

Source DB:  PubMed          Journal:  Acta Vet Scand        ISSN: 0044-605X            Impact factor:   1.695


  18 in total

1.  ISOLATION OF A NEWLY IDENTIFIED EQUINE RESPIRATORY VIRUS.

Authors:  J C WILSON; J T BRYANS; E R DOLL; L TUDOR
Journal:  Cornell Vet       Date:  1965-07

Review 2.  Vaccination against herpesvirus, fiction or reality?

Authors:  B Morein; M Merza
Journal:  Scand J Infect Dis Suppl       Date:  1991

3.  On blood volume and working capacity in horses. Studies of methodology and physiological and pathological variations.

Authors:  S Persson
Journal:  Acta Vet Scand       Date:  1967       Impact factor: 1.695

4.  Herpesviral diseases affecting reproduction in the horse.

Authors:  J T Bryans
Journal:  Vet Clin North Am Large Anim Pract       Date:  1980-11

Review 5.  Viral infections predisposing to bacterial infections.

Authors:  E L Mills
Journal:  Annu Rev Med       Date:  1984       Impact factor: 13.739

6.  Evaluation of upper respiratory tract function during strenuous exercise in racehorses.

Authors:  E A Morris; H J Seeherman
Journal:  J Am Vet Med Assoc       Date:  1990-02-01       Impact factor: 1.936

7.  Streptococci and Pasteurella spp. associated with disease of the equine lower respiratory tract.

Authors:  J L Wood; M H Burrell; C A Roberts; N Chanter; Y Shaw
Journal:  Equine Vet J       Date:  1993-07       Impact factor: 2.888

8.  Immune responses of specific pathogen free foals to EHV-1 infection.

Authors:  Y C Chong; W P Duffus
Journal:  Vet Microbiol       Date:  1992-10       Impact factor: 3.293

9.  Incidence of infections in pigs bred for slaughter revealed by elevated serum levels of interferon and development of antibodies to Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae.

Authors:  P Wallgren; K Artursson; C Fossum; G V Alm
Journal:  Zentralbl Veterinarmed B       Date:  1993-02

10.  Increased suppressor cell activity in cattle persistently infected with bovine virus diarrhoea virus.

Authors:  B Larsson
Journal:  Zentralbl Veterinarmed B       Date:  1988-05
View more
  3 in total

1.  The equine herpesvirus 2 E1 open reading frame encodes a functional chemokine receptor.

Authors:  G Camarda; G Spinetti; G Bernardini; C Mair; N Davis-Poynter; M C Capogrossi; M Napolitano
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Genomic analysis and mRNA expression of equine type I interferon genes.

Authors:  Olivier Detournay; David A Morrison; Bettina Wagner; Behdad Zarnegar; Eva Wattrang
Journal:  J Interferon Cytokine Res       Date:  2013-06-17       Impact factor: 2.607

3.  Comparison of the Levels of Pro-Inflammatory Cytokines Released in the Vastus Lateralis Muscle of Patients with Fibromyalgia and Healthy Controls during Contractions of the Quadriceps Muscle--A Microdialysis Study.

Authors:  Nikolaos Christidis; Bijar Ghafouri; Anette Larsson; Annie Palstam; Kaisa Mannerkorpi; Indre Bileviciute-Ljungar; Monika Löfgren; Jan Bjersing; Eva Kosek; Björn Gerdle; Malin Ernberg
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.